Total planned funding: $282,029,203
Allocations
Countries/Regions
Eswatini | $282,029,203 |
Organizational Types
Private Contractor | $74,418,235 |
Unknown | $53,274,613 |
University | $49,000,708 |
NGO | $44,840,095 |
Own Agency | $35,534,848 |
FBO | $10,806,488 |
Host Country Government Agency | $9,252,398 |
Other USG Agency | $2,445,094 |
Multi-lateral Agency | $2,406,724 |
Implementing Agency | $50,000 |
Program Areas
Care | $83,410,506 |
Treatment | $75,328,460 |
Prevention | $50,879,753 |
Governance and Systems | $31,836,782 |
Testing | $21,509,642 |
Management and Operations | $19,064,060 |
Budget Codes
HTXS: Treatment: Adult Treatment | $63,780,832 |
HBHC: Care: Adult Care and Support | $31,550,719 |
HKID: Care: Orphans and Vulnerable Children | $30,712,104 |
HVCT: Testing: HIV Testing and Counseling | $21,509,642 |
HVOP: Sexual Prevention: Other Sexual Prevention | $19,655,427 |
HVMS: Management and Operations | $19,064,060 |
HVSI: Strategic Information | $17,057,886 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $16,493,074 |
HVTB: Care: TB/HIV | $14,318,172 |
OHSS: Health Systems Strengthening | $10,643,160 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,725,559 |
PDTX: Treatment: Pediatric Treatment | $7,480,344 |
PDCS: Care: Pediatric Care and Support | $6,829,511 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $6,405,693 |
HLAB: Laboratory Infrastructure | $4,135,736 |
HTXD: Treatment: ARV Drugs | $4,067,284 |
HMBL: Biomedical Prevention: Blood Safety | $600,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$37,867,332
Countries/Regions
Not Available:
$34,964,747
Countries/Regions
Pact, Inc.:
$34,297,198
Countries/Regions
Chemonics International:
$16,579,695
Countries/Regions